These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 15972276)

  • 41. Sentinel lymph node biopsy examination for breast cancer patients with clinically negative axillary lymph nodes after neoadjuvant chemotherapy.
    Kinoshita T; Takasugi M; Iwamoto E; Akashi-Tanaka S; Fukutomi T; Terui S
    Am J Surg; 2006 Feb; 191(2):225-9. PubMed ID: 16442950
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predicting sentinel lymph node metastases in infiltrating breast carcinoma with vascular invasion.
    Jonjic N; Mustac E; Dekanic A; Marijic B; Gaspar B; Kolic I; Coklo M; Sasso F
    Int J Surg Pathol; 2006 Oct; 14(4):306-11. PubMed ID: 17041193
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients.
    Pendas S; Dauway E; Cox CE; Giuliano R; Ku NN; Schreiber RH; Reintgen DS
    Am Surg; 1999 Jun; 65(6):500-5; discussion 505-6. PubMed ID: 10366202
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases.
    Nos C; Harding-MacKean C; Fréneaux P; Trie A; Falcou MC; Sastre-Garau X; Clough KB
    Br J Surg; 2003 Nov; 90(11):1354-60. PubMed ID: 14598414
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Sentinel node biopsy in breast cancer].
    Imoto S; Wada N; Hasebe T; Ebihara S
    Gan To Kagaku Ryoho; 2002 Jul; 29(7):1120-4. PubMed ID: 12145990
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma: a multicenter study.
    Weaver DL; Krag DN; Ashikaga T; Harlow SP; O'Connell M
    Cancer; 2000 Mar; 88(5):1099-107. PubMed ID: 10699901
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The real-time intra-operative evaluation of sentinel lymph nodes in breast cancer patients using One Step Nucleic Acid Amplification (OSNA) and implications for clinical decision-making.
    Chaudhry A; Williams S; Cook J; Jenkins M; Sohail M; Calder C; Winters ZE; Rayter Z
    Eur J Surg Oncol; 2014 Feb; 40(2):150-7. PubMed ID: 24378008
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prediction of non-SN involvement in patients with SN isolated tumor cells or micrometastases.
    Pesce C; Balch C; Jacobs L
    Breast Dis; 2010; 31(2):99-106. PubMed ID: 21368372
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Changes in keratin expression during metastatic progression of breast cancer: impact on the detection of circulating tumor cells.
    Joosse SA; Hannemann J; Spötter J; Bauche A; Andreas A; Müller V; Pantel K
    Clin Cancer Res; 2012 Feb; 18(4):993-1003. PubMed ID: 22228641
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Patients with breast cancer and negative sentinel lymph node biopsy without additional axillary lymph node dissection: a follow-up study of up to 5 years.
    Domènech A; Benitez A; Bajén MT; Pla MJ; Gil M; Martín-Comín J
    Oncology; 2007; 72(1-2):27-32. PubMed ID: 17998787
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Correlation with bone metastasis and high expression of CK 19 mRNA measured by quantitative RT-PCR in the bone marrow of breast cancer patients.
    Tokunaga E; Ishida M; Kimura Y; Maehara Y
    Breast J; 2003; 9(5):440-2. PubMed ID: 12968974
    [No Abstract]   [Full Text] [Related]  

  • 52. Low specificity of cytokeratin 19 mRNA expression in the peripheral blood cells from patients with ovarian tumors.
    Takano H; Okamoto A; Fukushima K; Ochiai K; Tanaka T
    Oncol Rep; 2000; 7(5):1023-5. PubMed ID: 10948333
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Marker genes for circulating tumour cells predict survival in metastasized breast cancer patients.
    Weigelt B; Bosma AJ; Hart AA; Rodenhuis S; van 't Veer LJ
    Br J Cancer; 2003 Apr; 88(7):1091-4. PubMed ID: 12671691
    [TBL] [Abstract][Full Text] [Related]  

  • 54. NanoFlares for the detection, isolation, and culture of live tumor cells from human blood.
    Halo TL; McMahon KM; Angeloni NL; Xu Y; Wang W; Chinen AB; Malin D; Strekalova E; Cryns VL; Cheng C; Mirkin CA; Thaxton CS
    Proc Natl Acad Sci U S A; 2014 Dec; 111(48):17104-9. PubMed ID: 25404304
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Improved method for the detection of cytokeratin 19-positive cells in the peripheral blood of breast cancer patients.
    Alvero AB; Burtness BA; Ercan AG; Sapi E
    Lab Invest; 2004 May; 84(5):658-61. PubMed ID: 15105816
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Beyond the brain: huntingtin in breast cancers].
    Thion MS; Humbert S
    Med Sci (Paris); 2016 8-9; 32(8-9):674-7. PubMed ID: 27615166
    [No Abstract]   [Full Text] [Related]  

  • 57. Splicing Factor Transcript Abundance in Saliva as a Diagnostic Tool for Breast Cancer.
    Bentata M; Morgenstern G; Nevo Y; Kay G; Granit Mizrahi A; Temper M; Maimon O; Monas L; Basheer R; Ben-Hur A; Peretz T; Salton M
    Genes (Basel); 2020 Aug; 11(8):. PubMed ID: 32756364
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Divide and conquer: the genetic basis of molecular subclassification of breast cancer.
    Kristensen VN
    EMBO Mol Med; 2011 Apr; 3(4):183-5. PubMed ID: 21394915
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Challenges in breast pathology: new twists on old problems.
    Tavassoli FA
    Arch Pathol Lab Med; 2009 Jun; 133(6):852-4. PubMed ID: 19492876
    [No Abstract]   [Full Text] [Related]  

  • 60. Molecular profiling of individual tumor cells by hyperspectral microscopic imaging.
    Uhr JW; Huebschman ML; Frenkel EP; Lane NL; Ashfaq R; Liu H; Rana DR; Cheng L; Lin AT; Hughes GA; Zhang XJ; Garner HR
    Transl Res; 2012 May; 159(5):366-75. PubMed ID: 22500509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.